Found 4 matching trials
Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age.
PHASE2This study will evaluate the safety and immunogenicity of GSK Biologicals' ...
Location
GSK Investigational Site
Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age
PHASE2This study will evaluate the safety and immunogenicity of GSK Biologicals' ...
Location
GSK Investigational Site
Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose
PHASE2The current trial will evaluate the safety and immunogenicity of GSK Biolog...
Location
GSK Investigational Site
Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants
PHASE2This study will evaluate the safety and immunogenicity of GSK Biologicals' ...
Location
GSK Investigational Site